The present invention relates to stable growth hormone (GH) compounds, which through the introduction of cysteine residues have disulphide bridges, which make the compounds resistant to proteolytic degradation.
申请公布号
CA2747825(A1)
申请公布日期
2010.07.29
申请号
CA20102747825
申请日期
2010.01.22
申请人
NOVO NORDISK HEALTH CARE AG
发明人
OLSEN, OLE HVILSTED;BREINHOLT, JENS;SCHIOEDT, CHRISTINE BRUUN;DEMUTH, HELLE;NOERSKOV-LAURITSEN, LEIF;THYGESEN, PETER
